Singapore, Feb. 26 -- US-basedSunflower Therapeuticshas announced its first distribution agreement withPharmNXT Biotech, an Indian bioprocessing company. Through this agreement, Sunflower will commercially launch itsDaisy Petal Perfusion Bioreactor Systemin Asia, a significant step in the company's ongoing product commercialization.

Sunflower's innovative Daisy Petal perfusion fermentation system uses a single-use assembly designed specifically for intuitive installation and a simple user experience. The system's hardware and controls are engineered and optimised for in-vessel perfusion utilising a custom disposable stirred tank reactor outfitted with a unique in-vessel perfusion device that enables greater volumetric productivity from t...